ELIQUIS (apixaban)
(https://eliquis.com) 📸 Data Snapshot: May 29, 2026Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
There is a significant authority gap due to the complete absence of structured data (schema_json is null) and a broken technical hierarchy where 3 out of 4 primary pages fail to resolve. While the site references the FDA and healthcare providers, it lacks Person schema or sameAs links for medical directors or clinical leads, relying entirely on the brand’s weight rather than verifiable expert footprints.
The disconnect between the marketing claim ‘THE #1 PRESCRIBED ORAL BLOOD THINNER’ and the site’s technical state is severe. A market leader should demonstrate technical excellence, yet the site fails to provide the basic infrastructure to support its primary therapeutic claims. The marketing tone is authoritative, but the content delivery is broken.
Identity & Authority is read from the structured data first: whether the site declares who it is in machine-readable schema, with verifiable identity links. Below is the schema captured per page, then the external proof links that support (or fail to support) that identity.
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps
🛡️ Trust Signals — external proof links that back the declared identity
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 7 | 0 |
| /vte/ | 6 | 0 |
| /pediatric/ | 6 | 0 |
| /afib/ | 6 | 0 |
This page presents a snapshot of public data from ELIQUIS (apixaban), captured on May 29, 2026, to show how machine logic reads Identity & Authority signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to ELIQUIS (apixaban): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://eliquis.com to view the most current version of its content and see directly what this company is about and what it offers.